BCHE and Alzheimer disease: Through the structural optimizations, we hoped to find a more potent PARP-1 inhibitor, at the same time, in order to explore new MTDLs for the treatment of AD, the inhibitory activities against AChE and BChE enzymes of these compounds were also evaluated.